Following science and technology news from Europe

Provided by AGP

Sci-Tech Europe
Got News to Share?
Got News to Share? globe Explore more publications!

Sci-Tech Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Europe.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on April 19, 2026

Foldin Opens Public Beta: A Real-Life Social Network Designed Around the Courage to Show Up
Apr. 19, 2026

Foldin Opens Public Beta: A Real-Life Social Network Designed Around the Courage to Show Up

Indeterminate EIN Presswire
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
Apr. 19, 2026

Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

Indeterminate GlobeNewswire
Imagiportal Reports 300,000 Interactions And New Product Updates Six Months Post-Launch
Apr. 19, 2026

Imagiportal Reports 300,000 Interactions And New Product Updates Six Months Post-Launch

Indeterminate EIN Presswire
Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026
Apr. 19, 2026

Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026

Indeterminate GlobeNewswire
AIXPORT.AI Launches to Give Claude® Users Full Ownership of Their AI Work
Apr. 19, 2026

AIXPORT.AI Launches to Give Claude® Users Full Ownership of Their AI Work

Indeterminate EIN Presswire
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
Apr. 19, 2026

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma

Indeterminate GlobeNewswire
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
Apr. 19, 2026

Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting

Indeterminate GlobeNewswire
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Apr. 19, 2026

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Indeterminate GlobeNewswire
Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026
Apr. 19, 2026

Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026

Indeterminate GlobeNewswire
Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting
Apr. 19, 2026

Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire
Cregis Shines at Paris Blockchain Week 2026, Accelerating European Expansion
Apr. 19, 2026

Cregis Shines at Paris Blockchain Week 2026, Accelerating European Expansion

Indeterminate GlobeNewswire
Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage
Apr. 19, 2026

Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage

Indeterminate GlobeNewswire
Direct Meds GLP-1 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying
Apr. 19, 2026

Direct Meds GLP-1 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying

Indeterminate GlobeNewswire
Strovemont Capital Claims Evaluated: Is Strovemont Capital Trading Platform Legit? Hidden Features, Trust Facts & Real User Results
Apr. 19, 2026

Strovemont Capital Claims Evaluated: Is Strovemont Capital Trading Platform Legit? Hidden Features, Trust Facts & Real User Results

Indeterminate GlobeNewswire
Bramridge Trust Unveiled: Should You Join Bramridge Trust? Features, Performance, Fees & Real User Insights!
Apr. 19, 2026

Bramridge Trust Unveiled: Should You Join Bramridge Trust? Features, Performance, Fees & Real User Insights!

Indeterminate GlobeNewswire

Share us

on your social networks:
LinkedIn Facebook

Sign up for:

Sci-Tech Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.